The seasonality of pandemic and non-pandemic influenzas: The roles of solar radiation and vitamin D

International Journal of Infectious Diseases

Volumn 14, Issue 12, 2010, Pages

  Juzeniene, Asta ^a   Ma, Li Wei ^a   Kwitniewski, Mateusz ^a   Polev, Georgy A ^a   Lagunova, Zoya ^a   Dahlback, Arne ^b   Moan, Johan ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Immune effects; Influenza; Seasonality; Solar radiation; Vitamin D

Indexed keywords

VITAMIN D;

ARTICLE; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFLUENZA; JAPAN; LATITUDE; MORTALITY; NORWAY; PANDEMIC INFLUENZA; SEASONAL VARIATION; SINGAPORE; SWEDEN; ULTRAVIOLET B RADIATION; UNITED STATES; WINTER;

DISEASE OUTBREAKS; HUMANS; INFLUENZA, HUMAN; JAPAN; NORWAY; PANDEMICS; SEASONS; SINGAPORE; SKIN; SOLAR ENERGY; SWEDEN; ULTRAVIOLET RAYS; UNITED STATES; VITAMIN D;

EID: 78649635330     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.09.002     Document Type: Article

References (113)

1. Dowell S.F., Ho M.S. Seasonality of infectious diseases and severe acute respiratory syndrome-what we don't know can hurt us. Lancet Infect Dis 2004, 4:704-708.
2. Cox N.J., Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000, 51:407-421.
3. Eccles R. An explanation for the seasonality of acute upper respiratory tract viral infections. Acta Otolaryngol 2002, 122:183-191.
4. Lofgren E., Fefferman N.H., Naumov Y.N., Gorski J., Naumova E.N. Influenza seasonality: underlying causes and modeling theories. J Virol 2007, 81:5429-5436.
5. Lipsitch M., Viboud C. Influenza seasonality: lifting the fog. Proc Natl Acad Sci U S A 2009, 106:3645-3646.
6. Shaman J., Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proc Natl Acad Sci U S A 2009, 106:3243-3248.
7. Shaman J., Pitzer V.E., Viboud C., Grenfell B.T., Lipsitch M. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol 2010, 8:e1000316.
8. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009, 6(Suppl 6):S783-S790.
9. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006, 134:1129-1140.
10. Cannell J.J., Zasloff M., Garland C.F., Scragg R., Giovannucci E. On the epidemiology of influenza. Virol J 2008, 5:29.
11. Aloia J.F., Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007, 135:1095-1096.
12. Fleming D.M., Elliot A.J. Epidemic influenza and vitamin D. Epidemiol Infect 2007, 135:1091-1092.
13. Goldstein M.R., Mascitelli L., Pezzetta F. Pandemic influenza A (H1N1): mandatory vitamin D supplementation?. Med Hypotheses 2009, 74:756.
14. Moan J., Dahlback A., Ma L.W., Juzeniene A. Influenza, solar radiation and vitamin D. Dermatoendocrinol 2009, 1:307-309.
15. Grant W.B., Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinol 2009, 1:1-5.
16. Viboud C., Alonso W.J., Simonsen L. Influenza in tropical regions. PLoS Med 2006, 3:e89.
17. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006, 19:571-582.
18. Brundage J.F., Shanks G.D. What really happened during the 1918 influenza pandemic? The importance of bacterial secondary infections. J Infect Dis 2007, 196:1717-1718.
19. Morens D.M., Taubenberger J.K., Fauci A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008, 198:962-970.
20. Hussell T., Wissinger E., Goulding J. Bacterial complications during pandemic influenza infection. Future Microbiol 2009, 4:269-272.
21. Morens D.M., Taubenberger J.K., Harvey H.A., Memoli M.J. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med 2010, 38:e10-20.
22. Skog L., Hauska H., Linde A. The Russian influenza in Sweden in 1889-90: an example of Geographic Information System analysis. Euro Surveill 2008, 13:1-7.
23. Britten R.H. The incidence of epidemic influenza, 1918-1919. A further analysis according to age, sex, and color of records of morbidity and mortality obtained in surveys of 12 localities. Pub Health Rep 1932, 47:303-339.
24. Doshi P. Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health 2008, 98:939-945.
25. Suzuki Y., Taira K., Saito R., Nidaira M., Okano S., Zaraket H., Suzuki H. Epidemiologic study of influenza infection in Okinawa, Japan, from 2001 to 2007: changing patterns of seasonality and prevalence of amantadine-resistant influenza A virus. J Clin Microbiol 2009, 47:623-629.
26. Chew F.T., Doraisingham S., Ling A.E., Kumarasinghe G., Lee B.W. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 1998, 121:121-128.
27. Madronich S., McKenzie R.L., Bjorn L.O., Caldwell M.M. Changes in biologically active ultraviolet radiation reaching the Earth's surface. J Photochem Photobiol B 1998, 46:5-19.
28. Dahlback A., Stamnes K. A new spherical model for computing the radiation field available for photolysis and heating rate at twilight. Planet Space Sci 1991, 39:671-683.
29. Stamnes K., Tsay S.C., Wiscombe W.J., Jayaweera K. Numerically stable algorithm for discrete-ordinate-method radiative transfer in multiple scattering and emitting layered media. Appl Opt 1988, 27:2502-2509.
30. McPeters RD, Bhartia PK, Krueger AJ, Herman JR, Wellemeyer CG, Seftor CJ, et al. Earth Probe Total Ozone Mapping Spectrometer (TOMS) data products user's guide. Greenbelt, Maryland: NASA Technical Publication, NASA Goddard Space Flights Center; 1998, p. 1-64.
31. Vanicek K. Differences between ground Dobson, Brewer and satellite TOMS-8, GOME-WFDOAS total ozone observations at Hradec Kralove. Czech. Atmos Chem Phys 2006, 6:5163-5171.
32. Badarinath K.V., Kharol S.K., Kaskaoutis D.G., Kambezidis H.D. Influence of atmospheric aerosols on solar spectral irradiance in an urban area. J Atmos Sol Terr Phys 2007, 69:589-599.
33. Bais AF, Lubin D. Surface ultraviolet radiation: past, present, and future. In: Ennis CA, editor. Scientific assessment of ozone depletion: 2006. Global Ozone Research and Monitoring Project Report No. 50. Geneva, Switzerland: World Meteorological Organization; 2007, p. 7.1-7.53.
34. van der Leun J, Bornman JF, Tang X., Environmental effects of ozone depletion and its interactions with climate change. Progress Report. United Nations Environment Programme; 2009, p. 1-52.
35. Moan J., Dahlback A., Porojnicu A.C. At what time should one go out in the sun?. Adv Exp Med Biol 2008, 624:86-88.
36. Moan J., Dahlback A., Lagunova Z., Cicarma E., Porojnicu A.C. Solar radiation, vitamin D and cancer incidence and mortality in Norway. Anticancer Res 2009, 29:3501-3509.
37. Galkin O.N., Terenetskaya I.P. 'Vitamin D' biodosimeter: basic characteristics and potential applications. J Photochem Photobiol B 1999, 53:12-19.
38. MacLaughlin J.A., Anderson R.R., Holick M.F. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 1982, 216:1001-1003.
39. Chen J., Deng Y.M. Influenza virus antigenic variation, host antibody production and new approach to control epidemics. Virol J 2009, 6:30.
40. Taubenberger J.K., Morens D.M. The pathology of influenza virus infections. Annu Rev Pathol 2008, 3:499-522.
41. Kuiken T., Taubenberger J.K. Pathology of human influenza revisited. Vaccine 2008, 26(Suppl 4):D59-66.
42. Harper S.A., Bradley J.S., Englund J.A., File T.M., Gravenstein S., Hayden F.G., et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1003-1032.
43. Cunha B.A. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 2004, 18:141-155.
44. Tognotti E. Influenza pandemics: a historical retrospect. J Infect Dev Ctries 2009, 3:331-334.
45. Del Rio C., Hernandez-Avila M. Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic. Arch Med Res 2009, 40:677-680.
46. Tang J.W., Tambyah P.A., Lai F.Y., Lee H.K., Lee C.K., Loh T.P., et al. Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med 2010, 170:861-867.
47. Scalera N.M., Mossad S.B. The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med 2009, 121:43-47.
48. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009; 6:e1000207.
49. World Health Organization. Pandemic (H1N1) 2009-update 84. Geneva: World Health Organization; 2009. Available at: (accessed February 26, 2010). http://www.who.int/csr/don/2010_01_22/en/index.html.
50. Valleron A.J., Meurisse S., Boelle P.Y. Historical analysis of the 1889-1890 pandemic in Europe. Int J Infect Dis 2008, 12:e95.
51. Smith F.B. The Russian influenza in the United Kingdom, 1889-1894. Soc Hist Med 1995, 8:55-73.
52. Taubenberger J.K., Morens D.M. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 2006, 12:15-22.
53. Barry J.M. The site of origin of the 1918 influenza pandemic and its public health implications. J Transl Med 2004, 2:3.
54. Potter C.W. A history of influenza. J Appl Microbiol 2001, 91:572-579.
55. Olson D.R., Simonsen L., Edelson P.J., Morse S.S. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci U S A 2005, 102:11059-11063.
56. Ansart S., Pelat C., Boelle P.Y., Carrat F., Flahault A., Valleron A.J. Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respi Viruses 2009, 3:99-106.
57. Barry J.M., Viboud C., Simonsen L. Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain. J Infect Dis 2008, 198:1427-1434.
58. Bootsma M.C., Ferguson N.M. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci U S A 2007, 104:7588-7593.
59. Mathews J.D., McBryde E.S., McVernon J., Pallaghy P.K., McCaw J.M. Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9. BMC Infect Dis 2010, 10:128.
60. Johnson N.P., Mueller J. Updating the accounts: global mortality of the 1918-1920 'Spanish' influenza pandemic. Bull Hist Med 2002, 76:105-115.
61. Curson P., McCracken K. An Australian perspective of the 1918-1919 influenza pandemic. N S W Public Health Bull 2006, 17:103-107.
62. McLeod M.A., Baker M., Wilson N., Kelly H., Kiedrzynski T., Kool J.L. Protective effect of maritime quarantine in South Pacific jurisdictions, 1918-19 influenza pandemic. Emerg Infect Dis 2008, 14:468-470.
63. Lee V.J., Chen M.I., Chan S.P., Wong C.S., Cutter J., Goh K.T., Tambyah P.A. Influenza pandemics in Singapore, a tropical, globally connected city. Emerg Infect Dis 2007, 13:1052-1057.
64. Lee V.J., Wong C.S., Tambyah P.A., Cutter J., Chen M.I., Goh K.T. Twentieth century influenza pandemics in Singapore. Ann Acad Med Singapore 2008, 37:470-476.
65. Glezen W.P. Emerging infections: pandemic influenza. Epidemiol Rev 1996, 18:64-76.
66. Viboud C., Grais R.F., Lafont B.A., Miller M.A., Simonsen L. Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis 2005, 192:233-248.
67. Miller D.L., Pereira M.S., Clarke M. Epidemiology of the Hong Kong-68 variant of influenza A2 in Britain. Br Med J 1971, 1:475-479.
68. Lee V.J., Yap J., Ong J.B., Chan K.P., Lin R.T., Chan S.P., et al. Influenza excess mortality from 1950-2000 in tropical Singapore. PLoS One 2009, 4:e8096.
69. Moan J., Porojnicu A.C., Robsahm T.E., Dahlback A., Juzeniene A., Tretli S., Grant W. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B 2005, 78:189-193.
70. Holick M.F. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 1981, 77:51-58.
71. Grant W.B., Holick M.F. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 2005, 10:94-111.
72. Doraisingham S., Goh K.T., Ling A.E., Yu M. Influenza surveillance in Singapore: 1972-86. Bull World Health Organ 1988, 66:57-63.
73. Shih S.R., Chen G.W., Yang C.C., Yang W.Z., Liu D.P., Lin J.H., et al. Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol 2005, 43:1651-1661.
74. Li C.K., Choi B.C., Wong T.W. Influenza-related deaths and hospitalizations in Hong Kong: a subtropical area. Public Health 2006, 120:517-524.
75. Haus E., Smolensky M.H. Biologic rhythms in the immune system. Chronobiol Int 1999, 16:581-622.
76. Garssen J, van Loveren H. Effects of ultraviolet exposure on the immune system. Crit Rev Immunol 2001; 21:359-97.
77. Cantorna M.T., Zhu Y., Froicu M., Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004, 80:1717S-1720S.
78. Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R, Overbergh L., Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 2004; 89-90:449-52.
79. Bikle D.D. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008, 17:348-352.
80. van Etten E., Stoffels K., Gysemans C., Mathieu C., Overbergh L. Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev 2008, 66:S125-S134.
81. Andrianova A.I. [Prophylactic ultraviolet irradiation of preschool children of Moscow.]. Gig Sanit 1970, 35:30-33.
82. Bezberkhaia T.P. [The toughening of boarding school students by ultraviolet irradiation.]. Gig Sanit 1963, 28:94-97.
83. McSweeny K., Colman A., Fancourt N., Parnell M., Stantiall S., Rice G., et al. Was rurality protective in the 1918 influenza pandemic in New Zealand?. N Z Med J 2007, 120:U2579.
84. Chowell G., Bettencourt L.M., Johnson N., Alonso W.J., Viboud C. The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc Biol Sci 2008, 275:501-509.
85. Nishiura H., Chowell G. Rurality and pandemic influenza: geographic heterogeneity in the risks of infection and death in Kanagawa, Japan (1918-1919). N Z Med J 2008, 121:18-27.
86. Gannage-Yared M.H., Chemali R., Yaacoub N., Halaby G. Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 2000, 15:1856-1862.
87. McGrath J.J., Kimlin M.G., Saha S., Eyles D.W., Parisi A.V. Vitamin D insufficiency in south-east Queensland. Med J Aust 2001, 174:150-151.
88. Dowell S.F. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis 2001, 7:369-374.
89. Nelson R.J., Drazen D.L. Melatonin mediates seasonal adjustments in immune function. Reprod Nutr Dev 1999, 39:383-398.
90. Feigin RD, San Joaquin VH, Haymond MW, Wyatt RG., Daily periodicity of susceptibility of mice to pneumococcal infection. Nature 1969; 224:379-80.
91. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009, 169:384-390.
92. Grant W.B. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 2006, 92:65-79.
93. Embry A.F., Snowdon L.R., Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000, 48:271-272.
94. Lin R., White J.H. The pleiotropic actions of vitamin D. Bioessays 2004, 26:21-28.
95. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.
96. Laaksi I., Ruohola J.P., Tuohimaa P., Auvinen A., Haataja R., Pihlajamaki H., Ylikomi T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007, 86:714-717.
97. Armas L.A. Vitamin D, infections and immune-mediated diseases. Int J Clin Rheumatol 2009, 4:89-103.
98. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007, 179:2060-2063.
99. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004, 173:2909-2912.
100. Harder J., Glaser R., Schroder J.M. Human antimicrobial proteins effectors of innate immunity. J Endotoxin Res 2007, 13:317-338.
101. Laube D.M., Yim S., Ryan L.K., Kisich K.O., Diamond G. Antimicrobial peptides in the airway. Curr Top Microbiol Immunol 2006, 306:153-182.
102. Krutzik S.K., Hong P., Robles A., Corcoran K., Modlin R.L., Lee B. HIV-1 ssRNA triggers a vitamin D-dependent anti-viral pathway in human monocytes. FASEB J 2008, 22(672):22.
103. Hansdottir S., Monick M.M., Lovan N., Powers L., Gerke A., Hunninghake G.W. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010, 184:965-974.
104. Nimmerjahn F., Dudziak D., Dirmeier U., Hobom G., Riedel A., Schlee M., et al. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 2004, 85:2347-2356.
105. Akira S. Toll-like receptor signaling. J Biol Chem 2003, 278:38105-38108.
106. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 2004, 101:5598-5603.
107. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
108. Mahon B.D., Wittke A., Weaver V., Cantorna M.T. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003, 89:922-932.
109. Nashold F.E., Hoag K.A., Goverman J., Hayes C.E. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 2001, 119:16-29.
110. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
111. Daniel C., Sartory N.A., Zahn N., Radeke H.H., Stein J.M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008, 324:23-33.
112. Doherty P.C., Turner S.J., Webby R.G., Thomas P.G. Influenza and the challenge for immunology. Nat Immunol 2006, 7:449-455.
113. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010, 91:1255-1260.